Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind (Q39944735)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind |
scientific article |
Statements
1 reference
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind (English)
1 reference
Seock-Ah Im
1 reference
Norikazu Masuda
1 reference
Hiroji Iwata
1 reference
Massimo Cristofanilli
1 reference
Nicholas C Turner
1 reference
Jungsil Ro
1 reference
Angela DeMichele
1 reference
Sunil Verma
1 reference
Nadia Harbeck
1 reference
Ke Zhang
1 reference
Kathy Puyana Theall
1 reference
Yuqiu Jiang
1 reference
Cynthia Huang Bartlett
1 reference
Maria Koehler
1 reference
Dennis Slamon
1 reference
2 March 2016
1 reference
1 reference
Identifiers
1 reference